Patents by Inventor Arthur X. Li

Arthur X. Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, TREATMENT, AND COMPOSITIONS FOR CHARACTERIZING THYROID NODULE
    Publication number: 20230227913
    Abstract: The current disclosure provides, inter alia, method of determining benign nodules from thyroid cancer in a subject that is found to have a thyroid nodule, method of treating thyroid cancer in a subject detected to have thyroid cancer by the method of the current disclosure, compositions for determining benign nodules from thyroid cancer in a subject, and kits including reagents and composition for determining benign nodules from thyroid cancer in a subject.
    Type: Application
    Filed: July 20, 2022
    Publication date: July 20, 2023
    Inventors: Maria A. Hahn, John H. Yim, Yuman Fong, Arthur X. Li, Xiwei Wu
  • Methods, treatment, and compositions for characterizing thyroid nodule
    Patent number: 11505829
    Abstract: The current disclosure provides, inter alia, method of determining benign nodules from thyroid cancer in a subject that is found to have a thyroid nodule, method of treating thyroid cancer in a subject detected to have thyroid cancer by the method of the current disclosure, compositions for determining benign nodules from thyroid cancer in a subject, and kits including reagents and composition for determining benign nodules from thyroid cancer in a subject.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: November 22, 2022
    Assignee: City of Hope
    Inventors: Maria A. Hahn, John H. Yim, Yuman Fong, Arthur X. Li, Xiwei Wu
  • DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER
    Publication number: 20220349012
    Abstract: The present subject matter provides, inter alia, a method of diagnosing invasive ductal cancer or detecting invasive ductal cancer risk in a subject who has ductal carcinoma in situ, a method of treating breast cancer in a subject detected to have invasive ductal cancer or determined to be at risk of invasive ductal cancer, compositions for detecting invasive presence or potential in ductal carcinoma in situ in a subject, and kits including reagents and composition for detecting invasive presence or potential in ductal carcinoma in situ in a subject.
    Type: Application
    Filed: December 23, 2021
    Publication date: November 3, 2022
    Inventors: Maria A. Hahn, John H. Yim, Yuman Fong, Arthur X. Li, Xiwei Wu, Sun-Wing T.R. Tong
  • DNA methylation diagnostic test for breast cancer
    Patent number: 11242568
    Abstract: The present subject matter provides, inter alia, a method of diagnosing invasive ductal cancer or detecting invasive ductal cancer risk in a subject who has ductal carcinoma in situ, a method of treating breast cancer in a subject detected to have invasive ductal cancer or determined to be at risk of invasive ductal cancer, compositions for detecting invasive presence or potential in ductal carcinoma in situ in a subject, and kits including reagents and composition for detecting invasive presence or potential in ductal carcinoma in situ in a subject.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: February 8, 2022
    Assignee: City of Hope
    Inventors: Maria A. Hahn, John H. Yim, Yuman Fong, Arthur X. Li, Xiwei Wu, Sun-Wing T. R. Tong
  • DNA Methylation Diagnostic Test for Breast Cancer
    Publication number: 20190284633
    Abstract: The present subject matter provides, inter alia, a method of diagnosing invasive ductal cancer or detecting invasive ductal cancer risk in a subject who has ductal carcinoma in situ, a method of treating breast cancer in a subject detected to have invasive ductal cancer or determined to be at risk of invasive ductal cancer, compositions for detecting invasive presence or potential in ductal carcinoma in situ in a subject, and kits including reagents and composition for detecting invasive presence or potential in ductal carcinoma in situ in a subject.
    Type: Application
    Filed: December 28, 2018
    Publication date: September 19, 2019
    Applicant: City of Hope
    Inventors: Maria A. Hahn, John H. Yim, Yuman Fong, Arthur X. Li, Ms, Xiwei Wu, Sun-Wing T.R. Tong
  • METHODS, TREATMENT, AND COMPOSITIONS FOR CHARACTERIZING THYROID NODULE
    Publication number: 20170022570
    Abstract: The current disclosure provides, inter alia, method of determining benign nodules from thyroid cancer in a subject that is found to have a thyroid nodule, method of treating thyroid cancer in a subject detected to have thyroid cancer by the method of the current disclosure, compositions for determining benign nodules from thyroid cancer in a subject, and kits including reagents and composition for determining benign nodules from thyroid cancer in a subject.
    Type: Application
    Filed: July 22, 2016
    Publication date: January 26, 2017
    Inventors: MARIA A. HAHN, John H. Yim, Yuman Fong, Arthur X. Li, Xiwei Wu